Innocare Pharma-h Forecast, price target & analysts
Why the stock moved Beta
Innocare Pharma-h Target price 2026 - Analyst rating & recommendation
Innocare Pharma-h Classifications & Recommendation
Innocare Pharma-h Price Target
| Target Price | CN¥35.70 |
| Price | CN¥28.36 |
| Potential |
25.88%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Innocare Pharma-h 2027 .
The average Innocare Pharma-h target price is CN¥35.70.
This is
25.88%
register free of charge
CN¥39.83
40.43%
register free of charge
CN¥34.34
21.09%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Innocare Pharma-h to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Innocare Pharma-h stock has an average upside potential 2027 of
25.88%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion CN¥ | 2.37 | 2.66 |
| 135.27% | 11.96% | |
| EBITDA Margin | 25.32% | 14.23% |
| 160.30% | 43.80% | |
| Net Margin | 27.05% | 9.98% |
| 161.97% | 63.11% |
4 Analysts have issued a sales forecast Innocare Pharma-h 2026 . The average Innocare Pharma-h sales estimate is
This results in the following potential growth metrics:
4 Innocare Pharma-h Analysts have issued a net profit forecast 2026. The average Innocare Pharma-h net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share CN¥ | 0.38 | 0.15 |
| 246.15% | 60.53% | |
| P/E | 188.87 | |
| EV/Sales | 4.95 |
4 Analysts have issued a Innocare Pharma-h forecast for earnings per share. The average Innocare Pharma-h EPS is
This results in the following potential growth metrics and future valuations:
Innocare Pharma-h...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
